HomeRKV • CVE
add
Rakovina Therapeutics Inc
Previous close
$0.050
Day range
$0.050 - $0.060
Year range
$0.040 - $0.23
Market cap
8.46M CAD
Avg Volume
515.24K
P/E ratio
-
Dividend yield
-
Primary exchange
CVE
In the news
Financials
Income Statement
Revenue
Net income
| (CAD) | Mar 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 2.11M | 205.81% |
Net income | -2.18M | -189.72% |
Net profit margin | — | — |
Earnings per share | — | — |
EBITDA | -1.98M | -255.52% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (CAD) | Mar 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 75.82K | -57.21% |
Total assets | 4.78M | 3.69% |
Total liabilities | 2.39M | 43.15% |
Total equity | 2.39M | — |
Shares outstanding | 140.77M | — |
Price to book | 2.50 | — |
Return on assets | -95.76% | — |
Return on capital | -111.10% | — |
Cash Flow
Net change in cash
| (CAD) | Mar 2025info | Y/Y change |
|---|---|---|
Net income | -2.18M | -189.72% |
Cash from operations | -1.24M | -377.35% |
Cash from investing | — | — |
Cash from financing | — | — |
Net change in cash | -1.24M | -377.35% |
Free cash flow | -658.16K | -53,478.59% |
About
Founded
2019
Headquarters
Website
